Shimadzu Corp. Hits Day Low at JPY 3,672 Amid Price Pressure

Shimadzu Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.75% on May 12, 2026. The stock reached an intraday low of JPY 3,672.00, reflecting a challenging day in the market. In terms of performance metrics, Shimadzu's one-day performance contrasts sharply with the Japan Nikkei 225, which gained 0.52% on the same day. Over the past week, Shimadzu has shown a slight recovery with a 0.52% increase, although it remains down 3.22% over the past month. Year-to-date, the stock has declined by 11.9%, significantly underperforming the Nikkei 225, which has risen by 24.64% during the same period. Despite these fluctuations, Shimadzu maintains a strong management efficiency with a return on equity (ROE) of 10.87% and low debt levels, indicating a solid financial foundation. However, the stock's performance over the last year has been less favorable, generating a return of only 3.08%, compared to the Nikkei 225's impressive 66.67% return. As a large-cap company with a market capitalization of JPY 1,137,502 million, Shimadzu continues to navigate a competitive landscape.